NCT01853618
- Conditions
- Adenocarcinoma, Biliary Cancer, Biliary Tract Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Biliary Cancer
Explore clinical trials studying Biliary Cancer. Study availability and eligibility vary by location and protocol.
20 public trials
4 recruiting studies
Biliary Cancer trial results
NCT02626195
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +12 more
- Locations
-
- National Cancer Center Goyang-si, Gyeonggi-do, South Korea
NCT01401894
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +21 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT01661114
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +9 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
NCT02930252
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +7 more
- Locations
-
- General Hospital sanremo Sanremo, Imperia, Italy
NCT01838109
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +26 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT00551096
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +10 more
- Locations
-
- University of Colorado Denver Aurora, Colorado, United States
Completed
Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers
NCT00626158
- Conditions
- Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +9 more
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- Huntsman Cancer Center, University of Utah Salt Lake City, Utah, United States
Active, Not Recruiting
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
NCT04644068
- Conditions
- Additional Indications Below for Module 4 and 5, Adnexal Diseases, Biliary Cancer, +66 more
- Locations
-
- Research Site Boston, Massachusetts, United States
- Research Site Boston, Massachusetts, United States
- Research Site New York, United States
- Research Site Oklahoma City, Oklahoma, United States
Active, Not Recruiting
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
NCT02628067
- Conditions
- Adenocarcinoma, Adenoma, Advanced Cancer, +88 more
- Locations
-
Not specified